We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Material limitations in blood storage bags: A critical review of packaging-induced deterioration
AI summary Read the abstract
This review examines how the materials used in blood storage bags, primarily PVC plasticized with DEHP, contribute to the degradation of stored blood products. The study highlights that plasticizer leaching, poor gas barrier properties, and the generation of micro- and nanoplastics actively accelerate blood product deterioration, and argues for a shift toward active, intelligent preservation systems using alternative materials.
Blood and plasma storage bags are critical yet materially constrained components of transfusion medicine. The global reliance on plasticized polyvinyl chloride (PVC) containers that is primarily softened with di(2-ethylhexyl) phthalate (DEHP) introduces significant risks, including plasticizer leaching, poor gas barrier properties, and the generation of micro- and nanoplastics, all of which actively accelerate the biochemical and functional degradation of blood products (the “storage lesion”). This review provides a critical, interdisciplinary synthesis of how material deficiencies in current packaging compromise blood safety and quality. We analyze the mechanistic pathways of deterioration, evaluate emerging alternative materials (e.g., non-phthalate plasticizers, multilayer films, cyclic olefin copolymers), and assess advanced concepts such as active scavengers and intelligent sensors. Importantly, this work integrates the emerging concern of micro/nanoplastic contamination into the established framework of packaging-induced damage—a timely and underexplored risk. We highlight that while alternatives like DEHT and DINCH show promising in vitro performance, challenges in scalability, cost, and regulatory complexity hinder widespread adoption. Ultimately, we argue that the future of blood storage lies in a paradigm shift: from passive, degradative containers to active, intelligent preservation systems. This transition will require interdisciplinary innovation, combining high-barrier biocompatible materials with real-time monitoring and frugal design to extend shelf life, enhance transfusion safety, reduce environmental impact, and ensure global equity in healthcare. • Conventional PVC–DEHP blood bags actively contribute to storage lesions via plasticizer leaching, oxidative stress, and poor gas barrier performance. • Packaging-induced deterioration affects all blood components, accelerating protein denaturation, lipid peroxidation, and cellular damage. • Emerging alternatives (multilayer films, cyclic olefin copolymers, non-phthalate plasticizers) show improved biocompatibility and barrier properties but face scalability and cost challenges. • Micro- and nanoplastic release from current and emerging materials remains an unresolved safety concern. • Transitioning to active and intelligent blood packaging systems is critical to extend shelf life, enhance transfusion safety, and reduce environmental impact.
More Papers Like This
Microplastics Released from Blood Storage Bags: A Hidden Contribution to Red Blood Cell Storage Lesions
AI summary Read the abstract
Blood storage bags shed tiny plastic particles into the solutions used to preserve donated blood, and the longer blood sits in storage, the more microplastics build up and interact with red blood cells. This matters because these particles may contribute to blood cell damage during storage—but the good news is researchers found that filtering the solution before use removed most of the plastic and helped keep red blood cells healthier.
Weathered microplastics in human blood: unraveling the effect of structural changes at the particle surface on coagulation and platelet activation
AI summary Read the abstract
Researchers exposed human whole blood to microplastics that had been artificially aged to simulate real environmental weathering, finding that weathered plastics like polystyrene, PVC, and PET triggered significantly stronger blood clotting and platelet activation than fresh plastic particles. The findings suggest that the longer plastic sits in the environment and degrades, the more dangerous it may become to human cardiovascular health.
Microplastics in blood bags may affect red blood cells
AI summary Read the abstract
Scientists found tiny bits of plastic (microplastics) in bags used to store donated blood, likely coming from the plastic bags themselves, and these particles may affect the health of red blood cells over time. However, researchers caution it's too early to say blood bags need to be redesigned, more studies are needed to understand if this actually poses a risk to patients receiving blood transfusions.
Factors affecting micro(nano)plastic release during intravenous therapy: Direct blood exposure.
AI summary Read the abstract
This study systematically evaluated factors affecting micro(nano)plastic (MNP) release from medical infusion products during intravenous therapy. Results indicated that MNPs are released into IV fluid at measurable levels, potentially delivering plastic particles directly into the bloodstream of patients.
Effects of micro- and nanoplastics on blood cells in vitro and cardiovascular parameters in vivo, considering their presence in the human bloodstream and potential impact on blood pressure
AI summary Read the abstract
This review examines evidence that micro- and nanoplastics can enter the human bloodstream and interact with blood cells, with plastic particles already detected in human blood, blood clots, and artery plaques. While direct evidence linking microplastics to blood pressure changes in humans is still lacking, animal studies and the mechanisms identified -- including blood vessel damage and inflammation -- suggest cardiovascular effects are plausible.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.